| 09/29/2026 2:28 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 09/28/2026 4:38 PM | Bogart David Robert (2128417) Reporting Conexeu Sciences (2066836) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 4:25 PM | Conexeu Sciences (2066836) Subject Sharpe Jeffrey Nathan (2127816) Filed by | Form SCHEDULE 13D/A | |
| 09/15/2026 3:30 PM | Conexeu Sciences (2066836) Issuer Sharpe Jeffrey Nathan (2127816) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 1:47 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 09/14/2026 3:30 PM | Conexeu Sciences (2066836) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/10/2026 4:15 PM | Conexeu Sciences (2066836) Filer | Form 424B3 | |
| 09/10/2026 3:30 PM | Conexeu Sciences (2066836) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2026 7:42 PM | Conexeu Sciences (2066836) Issuer Purcell Lynn Sebastian (2128469) Reporting | Form 4/A | |
| 09/09/2026 7:22 PM | Conexeu Sciences (2066836) Issuer Purcell Lynn Sebastian (2128469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 11:00 AM | Conexeu Sciences (2066836) Subject Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund (2152069) Filed by | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for CNXU and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Conexeu Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/04/2026 10:49 AM | Conexeu Sciences (2066836) Subject Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund (2152069) Filed by | Form SCHEDULE 13G | |
| 08/31/2026 11:58 AM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 08/18/2026 5:03 AM | Bogart David Robert (2128417) Filed by Conexeu Sciences (2066836) Subject | Form SCHEDULE 13G | |
| 08/18/2026 5:04 AM | Conexeu Sciences (2066836) Subject Sharpe Jeffrey Nathan (2127816) Filed by | Form SCHEDULE 13D | |
| 07/20/2026 11:33 AM | Conexeu Sciences (2066836) Subject Paisley Capital Holdings Corp (2143053) Filed by | Form SCHEDULE 13G | |
| 07/07/2026 4:12 PM | Conexeu Sciences (2066836) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/29/2026 5:14 AM | Conexeu Sciences (2066836) Issuer Costa Andrew (1874984) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/24/2026 3:15 PM | Burke April Lynn (2141993) Reporting Conexeu Sciences (2066836) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/23/2026 8:51 PM | Bastiani-Posner Ana Lucia (2141771) Reporting Conexeu Sciences (2066836) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/23/2026 7:15 PM | Conexeu Sciences (2066836) Issuer Purcell Lynn Sebastian (2128469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 12:25 PM | Conexeu Sciences (2066836) Issuer Wright Michael G. (2137182) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:42 PM | Conexeu Sciences (2066836) Filer | Form 424B3 | |
| 06/15/2026 3:30 PM | Conexeu Sciences (2066836) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/12/2026 1:32 PM | Conexeu Sciences (2066836) Filer | Form D/A | |
| 06/10/2026 2:18 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 06/09/2026 3:30 PM | Conexeu Sciences (2066836) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 10:39 AM | Conexeu Sciences (2066836) Issuer Wright Michael G. (2137182) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 1:05 PM | Conexeu Sciences (2066836) Issuer Wright Michael G. (2137182) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/26/2026 5:16 AM | Conexeu Sciences (2066836) Issuer Sharpe Jeffrey Nathan (2127816) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 4:11 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 05/21/2026 4:14 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 05/15/2026 5:43 PM | Conexeu Sciences (2066836) Issuer Lorenc Zbigniew Paul (2127734) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:17 PM | Conexeu Sciences (2066836) Filer | Form 424B3 | |
| 05/14/2026 7:12 PM | Conexeu Sciences (2066836) Issuer Purcell Lynn Sebastian (2128469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 7:19 PM | Conexeu Sciences (2066836) Issuer OnePointTwo Capital Ventures LLC (2080820) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 11:15 PM | Conexeu Sciences (2066836) Filer | Form EFFECT | |
| 05/11/2026 8:41 PM | Conexeu Sciences (2066836) Issuer OnePointTwo Capital Ventures II LLC (2080821) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 8:27 PM | Conexeu Sciences (2066836) Issuer OnePointTwo Capital Ventures LLC (2080820) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 7:58 PM | Conexeu Sciences (2066836) Issuer Purcell Lynn Sebastian (2128469) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:55 PM | Bogart David Robert (2128417) Reporting Conexeu Sciences (2066836) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
They didn't warn anyone in 1971. This time someone is warning you. (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade.
Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction.
A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now |
| 05/11/2026 5:42 PM | Conexeu Sciences (2066836) Issuer Lorenc Zbigniew Paul (2127734) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:47 PM | Conexeu Sciences (2066836) Issuer Pilcher Brian Keith (2127828) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:51 PM | Conexeu Sciences (2066836) Issuer Farberg Aaron Solomon (2128176) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:30 PM | Conexeu Sciences (2066836) Issuer Sharpe Jeffrey Nathan (2127816) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:34 PM | Chavez-Munoz Claudia Itze (2128415) Reporting Conexeu Sciences (2066836) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:18 PM | Conexeu Sciences (2066836) Issuer Harrison Miles David (2127715) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 5:22 PM | Conexeu Sciences (2066836) Issuer Inouye Stephen Douglas (2128444) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 4:21 PM | Conexeu Sciences (2066836) Filer | Form 424B4 | |
| 05/11/2026 3:46 PM | Conexeu Sciences (2066836) Filer | Form CERT | |
| 05/11/2026 9:39 AM | Conexeu Sciences (2066836) Filer | Form 8-A12B | |
| 04/17/2026 1:52 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 04/09/2026 6:48 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 04/06/2026 4:05 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 03/26/2026 2:35 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 03/04/2026 8:32 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 02/27/2026 8:14 PM | Conexeu Sciences (2066836) Filer | Form C-AR | |
| 02/04/2026 1:34 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |
| 02/03/2026 4:29 PM | Conexeu Sciences (2066836) Filer | Form S-1/A | |
| 11/28/2025 3:02 PM | Conexeu Sciences (2066836) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 11/20/2025 2:32 PM | Conexeu Sciences (2066836) Filer | Form D Notice of Exempt Offering of Securities | |